Avalo Therapeutics (AVTX) Gross Profit (2017 - 2024)
Avalo Therapeutics (AVTX) reported Gross Profit of -$465000.0 for Q3 2024, down 4127.27% on a YoY basis from $11546.3 in Q4 2023, and down 35.57% quarter-over-quarter from -$343000.0 in Q2 2024.
Avalo Therapeutics (AVTX) Gross Profit (2017 - 2024) Analysis & Trends
Avalo Therapeutics has reported Gross Profit for 8 years, with the latest figure at -$465000.0 in Q3 2024.
- For the quarter ending Q3 2024, Gross Profit fell 4127.27% year-over-year to -$465000.0; the trailing twelve-month figure through Sep 2024 stood at -$96000.0 (down 177.42% YoY), and the FY2023 full-year result was $640000.0, down 95.62% from the prior year.
- Gross Profit for Q3 2024 stood at -$465000.0, down from -$343000.0 in the prior quarter.
- The five-year high for Gross Profit was $14.4 million in Q3 2022, with the low at -$623000.0 in Q4 2020.
- Historically, Gross Profit has averaged $1.1 million across 5 years, with a median of $276000.0 in 2022.
- Annual changes were most pronounced in 2022 — Gross Profit surged 3162.67% — and 2024, when it plunged 4127.27%.
- Avalo Therapeutics' Gross Profit stood at -$623000.0 in 2020, then jumped by 67.09% to -$205000.0 in 2021, then soared by 234.63% to $276000.0 in 2022, then jumped by 186.96% to $792000.0 in 2023, then tumbled by 158.71% to -$465000.0 in 2024.
- The last three Gross Profit figures came in at -$465000.0 (Q3 2024), -$343000.0 (Q2 2024), and -$80000.0 (Q1 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Avalo Therapeutics | 295.77 Mn | 295.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -465,000.00 |
| Sep 30, 2024 | -465,000.00 |
| Jun 30, 2024 | -343,000.00 |
| Jun 30, 2024 | -343,000.00 |
| Mar 31, 2024 | -80,000.00 |
| Mar 31, 2024 | -80,000.00 |
| Dec 31, 2023 | 792,000.00 |
| Dec 31, 2023 | 792,000.00 |
| Sep 30, 2023 | -11,000.00 |
| Sep 30, 2023 | -11,000.00 |
| Jun 30, 2023 | -65,000.00 |
| Jun 30, 2023 | -65,000.00 |
| Mar 31, 2023 | -76,000.00 |
| Mar 31, 2023 | -76,000.00 |
| Dec 31, 2022 | 276,000.00 |
| Dec 31, 2022 | 276,000.00 |
| Sep 30, 2022 | 14.42 Mn |
| Sep 30, 2022 | 14.42 Mn |
| Jun 30, 2022 | -534,000.00 |
| Jun 30, 2022 | -534,000.00 |